LRG1 May Accelerate the Progression of ccRCC via the TGF-β Pathway

Clear cell renal cell carcinoma (ccRCC) accounts for 60-70% of renal cell carcinoma (RCC) cases. It is an urgent mission to find more therapeutic targets for advanced ccRCC. Leucine-rich a-2-glycoprotein 1 (LRG1) is a secreted protein associated with a variety of malignancies. Our study focused on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Quan, Wang, Shuqiang, Liu, Shuxin, Chen, Xiangmei, Cai, Guangyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149433/
https://www.ncbi.nlm.nih.gov/pubmed/32337221
http://dx.doi.org/10.1155/2020/1285068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149433/
https://www.ncbi.nlm.nih.gov/pubmed/32337221
http://dx.doi.org/10.1155/2020/1285068

Ejemplares similares